Pages:
Author

Topic: GENEXI - Biotech Accelerator [ Hi-Tech Bio&Med ] - page 5. (Read 33195 times)

jr. member
Activity: 112
Merit: 2
Meet our experts!

Alexander Novoselov, Biotech Analyst




Alexander is a Director of the Moscow Society of Dermatologists. He joined Genexi in 2016, following five years with Russian Dermatology Academic Research Centre and over a decade of working for global health, development and public sector organisations. Alexander holds a Masters degree in Medicine.

Join our community: https://t.me/Genexi
jr. member
Activity: 112
Merit: 2
It's really good idea! Interesting vision, amazing vision.  Good luck follows!

Thank you very much amigo! Grin
member
Activity: 294
Merit: 10
It's really good idea! Interesting vision, amazing vision.  Good luck follows!
newbie
Activity: 124
Merit: 0
The project intend to build transparency ecosystem for biotech and encourage the participation by using token as a media.
jr. member
Activity: 112
Merit: 2
Get acquainted with the members of GENEXI Advisory Board: https://bitcoingarden.org/genexi-biotech-accelerator-announces-advisory-board/

Join our community: https://t.me/Genexi
jr. member
Activity: 112
Merit: 2


The drug industry is a target for counterfeiting because pharmaceuticals have high value and high utilization, and because the complex development process means large amounts of chemicals cross borders. Many of those countries do not have the same regulatory requirements as the United States. The World Health Organization estimates that about 30 percent of countries worldwide do not have a functional drug regulation agency equivalent to the FDA.
jr. member
Activity: 112
Merit: 2
Looks really hilarious, another project that will not reach soft cap, sorry for crushing your dreams...

Thank you for your interest in our project, we have almost reached half of the softcap and there are still almost two months left...

jr. member
Activity: 45
Merit: 1
Looks really hilarious, another project that will not reach soft cap, sorry for crushing your dreams...
jr. member
Activity: 112
Merit: 2

GENEXI Foundation Modus Operandi:

1. Identifying Suitable Companies for Investment
2. Monitoring the Competition
3. Identifying Value Drivers
4. Ensuring Project Professionalization
5. Developing a Strategic Plan
6. Providing Networking Opportunities
jr. member
Activity: 112
Merit: 2
Dear community members!

✔️GENEXI Official ICO is LIVE✔️

Round 3: 06.07 – 26.07
Price: 1 GEN token = 0.01 USD
Bonus: 5%

✅ Follow this link to get started: https://my.genexi.io/register

Join our community: https://t.me/Genexi

member
Activity: 420
Merit: 10
Supporting on Technology and medicine can be a best things to do these day, For the world to be able to grow then we need to increase the technology and the health of people in order to be able to build the future
jr. member
Activity: 112
Merit: 2

Original product is a must-have for each consumer. Serialization is a primary part of ensuring the product's authenticity. However, there are risks. Looking globally, approximately $15 billion of API (Active Pharmaceutical Ingredient) will be exported out of India alone this year. Though it may be serialized, it doesn’t mean there is not a possibility for drugs to sneak in and out of the supply chain. In global pharma field there are no strict regulations. Policy does not balance manufacturing and distribution in every part of the world. Thus, manufacturers are responsible for playing by the rules in whatever geography they operate.
jr. member
Activity: 112
Merit: 2
GENEXI Platform will provide extra services for promotion and development, giving access to its own expert boards and accommodating third party service providers within the ecosystem.
GENEXI Ecosystem will allow a wide range of participants to join the development; aside from the general involvement of every member into the supply chain, GENEXI will provide the marketplace for side services, such as research centers, laboratories and institutes.


jr. member
Activity: 112
Merit: 2
The global blockchain technology market is forecast to grow to 2.3 billion U.S. dollars by 2021. Read the new article of our CEO on Medium: https://medium.com/@Zhelyaskov/opportunity-rich-time-e6c67bedc559
jr. member
Activity: 112
Merit: 2
Meet our experts!

Malcolm Tan, Advisor




Malcolm Tan is an established Singaporean lawyer-entrepreneur with extensive experience in construction, telecommunications, engineering, retail, IT, and financial industries. Malcolm is skilled in litigation, corporate law, and M&A. He previously held legal counsel positions in both global and regional capacities across the Asia-Pacific region, MENA, and North America. Malcolm has been involved in corporate advisory and corporate finance field, in deals from angel to VC and PE, and also Pre-IPO and IPO deals.
full member
Activity: 364
Merit: 100
the concept provided by this project is interesting and certainly will be very useful to help the community. but unfortunately you are not holding a bounty campaign to promote your project. I wait for the innovation that will be given this project for the future and good luck as expected.
jr. member
Activity: 112
Merit: 2
GENEXI Foundation will combine its experience in project evaluation and development, as well as scientific and medical expertise, to select the most perspective studies in the process of continuous market monitoring and research. Every project will be evaluated based on particular metrics.

Join our Telegram chat: https://t.me/Genexi
member
Activity: 252
Merit: 13
interesting project, the thread presented has explained in detail about the project and the road map is good. but unfortunately you do not hold a bounty campaign to make ICO more interesting. monitor permission to see how it progresses.
jr. member
Activity: 112
Merit: 2
For those who like the news in a short and brief form, follow us on Twitter: https://twitter.com/Genexi_bio
jr. member
Activity: 112
Merit: 2
Follow the latest news and monitor GENEXI's development reading our Founder's blog on Medium: https://medium.com/@Zhelyaskov
Pages:
Jump to: